KATHARINE PICCOLI: Open Payments
NPI 1245302652 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 114 payments from 15 companies in 2025. Trend: 2023 $1,762 · 2024 $1,918 · 2025 $2,451
Food & beverage: $2,451
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $315 |
| Janssen Biotech, Inc. | 9 | $243 |
| ABBVIE INC. | 16 | $243 |
| GENZYME CORPORATION | 8 | $219 |
| Arcutis Biotherapeutics, Inc. | 5 | $209 |
| LEO Pharma Inc. | 9 | $206 |
| Regeneron Healthcare Solutions, Inc. | 9 | $199 |
| UCB, Inc. | 10 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $144 |
| Organon LLC | 6 | $132 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Zoryve, Bimzelx, SKYRIZI, ILUMYA, ADBRY.
Industry payments across MD — which companies pay providers there.
